Volume 27, Number 2—February 2021
CME ACTIVITY - Synopsis
Zika Virus–Associated Birth Defects, Costa Rica, 2016–2018
Table 3
Clinical and neuroimaging features |
No. (%) cases |
||
---|---|---|---|
Confirmed, n = 11 |
Probable, n = 11 |
Total, n = 22 |
|
Brain defects | 9 (82) | 9 (82) | 18 (82) |
Ventriculomegaly/Hydrocephaly | 8 (73) | 4 (36) | 12 (55) |
Intracranial calcifications | 8 (73) | 3 (27) | 11 (50) |
Cerebral atrophy | 4 (36) | 6 (55) | 10 (45) |
Corpus callosum abnormalities | 4 (36) | 4 (36) | 8 (36) |
Abnormal cortical formation | 3 (27) | 3 (27) | 6 (27) |
Cerebellar abnormalities | 2 (18) | 0 | 2 (9) |
Porencephaly | 0 | 1 (9) | 1 (5) |
Other | 0 | 2 (18) | 2 (9) |
No brain defects |
2 (18) |
2 (18) |
4 (18) |
Eye anomalies | 5 (45) | 4 (36) | 9 (41) |
Chorioretinal scarring in the macula | 4 (36) | 2 (18) | 6 (27) |
Optic nerve | 3 (27) | 2 (18) | 5 (23) |
Other | 0 | 0 | 0 |
No eye anomalies | 6 (55) | 5 (45) | 11 (50) |
No data reported† |
0 |
2 (18) |
2 (9) |
Microcephaly | 11 (100) | 9 (82) | 20 (91) |
Severe | 9 (82) | 5 (45) | 14 (64) |
Mild–moderate | 2 (18) | 4 (36) | 6 (27) |
No microcephaly |
0 |
2 (18) |
2 (9) |
Hearing abnormalities, ABR evaluation | 2 (18) | 0 | 2 (9) |
Sensorineural hearing loss | 2 (18) | 0 | 2 (9) |
No hearing abnormalities | 7 (64) | 6 (55) | 13 (59) |
Not evaluated by ABR‡ |
2 (18) |
5 (45) |
7 (32) |
Neurodevelopmental abnormalities | 11 (100) | 9 (82) | 21 (95) |
Body tone abnormalities | 10 (91) | 8 (73) | 18 (82) |
Possible developmental delay§ | 10 (91) | 8 (73) | 18 (82) |
Possible visual impairment | 8 (73) | 4 (36) | 12 (55) |
Congenital contractures | 5 (45) | 5 (45) | 10 (45) |
Seizures, excluding febrile | 7 (64) | 1 (9) | 8 (36) |
Movement abnormalities | 6 (55) | 5 (45) | 11 (50) |
Swallowing abnormalities | 6 (55) | 3 (27) | 9 (41) |
No abnormalities | 0 | 1 (9) | 1 (5) |
No data reported† | 0 | 1 (9) | 1 (5) |
*ABR, auditory brain response test. †These infants had a normal result for newborn hearing screening by otoacoustic emissions testing and were not evaluated by ABR because they were lost to follow-up. Three infants did not have any hearing screening because they died soon after birth. ‡Includes infants for whom an evaluation was not performed or records were not obtainable. §For 4 children (1 with a confirmed case and 3 with a possible case), developmental delay was not evaluated by any specific method.
Page created: December 07, 2020
Page updated: January 21, 2021
Page reviewed: January 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.